PM
Pruzanski Mark Director
Board M
US US · SEC (Form 4)
Discover the detailed record of transactions filed by Pruzanski Mark, Director. Officer active across 1 companies, notably Intercept Pharmaceuticals, INC.. Cumulatively, 16 filings have been published. The latest transaction was filed on 30 November 2021 — Attribution. Regulator: SEC (Form 4). All data is openly available.
Declarations 16 total
€93,537 6,138 shares @ €15.2389 13.1% of flow
Common Stock
SEC:0001104659-21-145908 · 30 Nov 2021
€93,537 6,138 shares @ €15.2389 6.5% of flow
Common Stock
SEC:0001104659-21-145908:0 · 30 Nov 2021
€88,574 6,138 shares @ €14.4305 12.4% of flow
Common Stock
SEC:0001104659-21-132983 · 29 Oct 2021
€88,574 6,138 shares @ €14.4305 6.2% of flow
Common Stock
SEC:0001104659-21-132983:0 · 29 Oct 2021
€78,725 6,136 shares @ €12.83 11.0% of flow
Common Stock
SEC:0001104659-21-122560 · 30 Sept 2021
€78,725 6,136 shares @ €12.83 5.5% of flow
Common Stock
SEC:0001104659-21-122560:0 · 30 Sept 2021
€77,490 6,138 shares @ €12.6246 10.8% of flow
Common Stock
SEC:0001104659-21-112144 · 31 Aug 2021
€77,490 6,138 shares @ €12.6246 5.4% of flow
Common Stock
SEC:0001104659-21-112144:0 · 31 Aug 2021
€89,182 6,138 shares @ €14.5296 12.5% of flow
Common Stock
SEC:0001104659-21-099031 · 30 Jul 2021
€89,182 6,138 shares @ €14.5296 6.2% of flow
Common Stock
SEC:0001104659-21-099031:0 · 30 Jul 2021
€103,347 6,136 shares @ €16.8427 14.5% of flow
Common Stock
SEC:0001104659-21-088399 · 30 Jun 2021
€103,347 6,136 shares @ €16.8427 7.2% of flow
Common Stock
SEC:0001104659-21-088399:0 · 30 Jun 2021
€83,715 6,138 shares @ €13.6388 11.7% of flow
Common Stock
SEC:0001104659-21-075896 · 28 May 2021
€83,715 6,138 shares @ €13.6388 5.9% of flow
Common Stock
SEC:0001104659-21-075896:0 · 28 May 2021
€100,114 6,138 shares @ €16.3106 7.0% of flow
Common Stock
SEC:0001104659-21-061181:0 · 30 Apr 2021
€100,114 6,138 shares @ €16.3106 14.0% of flow
Common Stock
SEC:0001104659-21-061181 · 30 Apr 2021
About Pruzanski Mark Mark Pruzanski is an executive at INTERCEPT PHARMACEUTICALS, INC.